LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTC.BB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that the company will present at the Rodman & Renshaw 13th Annual Global Investment Conference at the Waldorf Astoria in New York City on September 13th. The presentation will be given at 9:10 a.m. Eastern Daylight Time in Starlight South room.
